Bayer
Bayer justifies Brandicourt’s ‘golden handshake’
February 27, 2015Medical Communications, Sales and Marketing Bayer, CEO, Sanofi, dekkers, olivier brandicourt, payments, wages
Bayer has confirmed that Sanofi’s justification for the controversial starter package it is giving to the German firm’s Olivier Brandicourt …
Bayer MaterialScience gets new chairman
February 27, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Werner Baumann, richard pott
Dr Richard Pott has been appointed to the supervisory board at Bayer MaterialScience as its new chairman. Pott replaces Werner …
New drugs give Bayer record sales
February 26, 2015Sales and Marketing Bayer, Eylea, Radium-223 chloride, Stivarga, Xarelto, adempas, aflibercept, dekkers, german, regorafenib, riociguat, xofigo
Bayer has reported strong financial results for 2014 driven primary by sales of new medicines, although controversy surrounding its anti-clotting …
Sanofi confirms new chief executive
February 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Chris Viehbacher, Sanofi, praluent
Bayer chairman Olivier Brandicourt has been named as Sanofi’s new chief executive to replace Chris Viehbacher who was ejected from …
UK pharma commits at least ‘one code breach a week’
February 18, 2015Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code
Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …
New chairman for Bayer’s Central Works Council
February 4, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Zühlke, Thomas de Win, central works council
Oliver Zühlke has succeeded Thomas de Win as chairman at the Central Works Council of Bayer as he steps down …
Bayer launches major new stroke trial
January 27, 2015Research and Development, Sales and Marketing Bayer, Canadian Stroke Prevention Intervention Network, Population Health Research Institute, Xarelto, rivaroxaban, stroke
Bayer is enrolling more than 7,000 people in a trial to test whether its blood-thinning drug Xarelto can successfully prevent …
NICE recommends Bayer heart attack drug
January 26, 2015Sales and Marketing ACS, Bayer, J&J, JJ, NICE, Xarelto, q4, rivaroxaban
NICE has recommended Xarelto in final draft guidance as an option for preventing blood clots in people who have had …
Boehringer trials Pradaxa anti-bleeding antidote
December 11, 2014Sales and Marketing BMS, Bayer, Boehringer, Eliquis, Pradaxa, ash, dabigatran, idarucizumab
Boehringer Ingelheim says that its investigational drug can safely reverse the blood-thinning effect of its anti-clotting drug Pradaxa (dabigatran). The …
Mixed results for new leukaemia drugs
December 9, 2014Research and Development, Sales and Marketing AML, Bayer, Nexavar, Qinprenzo, Sunesis Pharmaceuticals, sorafenib
Two trials of new drugs for acute myeloid leukaemia (AML) have shown promising results in younger and older groups of …
Bayer files haemophilia drug in EU
December 5, 2014Sales and Marketing BAY 81-8973, Bayer, Biogen IDEC, EMA, elocta, haemophilia a, kogenate
Bayer has submitted a marketing authorisation application to the EMA for its haemophilia A therapy BAY 81-8973. The German firm’s …
New head of industrial operations at Bayer
November 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Klaus Schäfer
Bayer MaterialScience is getting a new head of industrial operations and technology as Dr Tony Van Osselaer retires from the …
Supervisory board member joins Bayer
October 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Otmar Wiestler
Professor Otmar Wiestler has been appointed to the supervisory board at German pharma giant Bayer. He replaces Dr Klaus Kleinfeld …
Bayer hires litigation head from Pfizer
July 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Malini Moorthy, Pfizer
Bayer Healthcare has appointed Malini Moorthy to head up its litigation department in the US. Moorthy joins the German firm from …
Bayer in Oxford tie-up
July 11, 2014Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university
Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …
Latest content
